KEGG: xla:446861
UniGene: Xl.32918
The UPF0668 protein C10orf76 homolog is a full-length protein (689 amino acids) found in Xenopus laevis (African clawed frog). It belongs to the UPF0668 family, with the specific UniProt accession number Q6DCT2 . The protein's function is not fully characterized (hence the "UPF" designation which stands for "Uncharacterized Protein Family"), but it is homologous to the human C10orf76 protein. The protein has a complete amino acid sequence starting with MAQIEKKVGLLRKSSASKKPLKEK and contains various structural domains that suggest potential roles in cellular processes .
The most documented expression system for the Xenopus laevis UPF0668 protein C10orf76 homolog is Escherichia coli (E. coli). This bacterial expression system efficiently produces the full-length protein (amino acids 1-689) with an N-terminal His-tag for purification purposes . The bacterial expression system is preferred for its cost-effectiveness, scalability, and ability to produce significant quantities of the recombinant protein for research applications. Alternative expression systems, such as insect or mammalian cells, may be considered when post-translational modifications are critical for experimental purposes.
For optimal storage and handling of Recombinant Xenopus laevis UPF0668 protein C10orf76 homolog:
Upon receipt, briefly centrifuge the vial to bring contents to the bottom before opening
Reconstitute the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 50% for long-term storage
Store at -20°C/-80°C in small working aliquots to prevent freeze-thaw cycles
For working solutions, store aliquots at 4°C for up to one week
Avoid repeated freeze-thaw cycles as they significantly reduce protein activity
The protein is typically supplied in a Tris/PBS-based buffer with 6% Trehalose at pH 8.0, which helps maintain stability during lyophilization and storage .
Immunodepletion in Xenopus egg extracts is a powerful technique to study the function of UPF0668 protein C10orf76 homolog:
Preparation of antibody-coupled beads:
Wash Protein A Dynabeads with antibody washing/coupling buffer
Incubate beads with specific antibodies against UPF0668 protein C10orf76 homolog
Wash to remove unbound antibodies
Immunodepletion procedure:
Incubate the prepared beads with CSF-arrested Xenopus laevis egg extract
Allow the antibody to capture the target protein
Magnetically separate the beads containing the immunocomplexes
Collect the depleted extract for experimental use
Verification:
This method allows researchers to examine the phenotypic consequences of removing the protein from the extract, providing insights into its functional role in various cellular processes.
Two primary methods are recommended for protein add-back experiments after immunodepletion:
Dialyze purified recombinant protein into a compatible buffer (phosphate or HEPES-based)
Concentrate to at least 20× the endogenous concentration
Add directly to the depleted extract
Prepare template DNA with appropriate promoter (SP6 or T7)
Perform in vitro transcription using mMESSAGE mMACHINE kit
Purify the mRNA
Add mRNA directly to the depleted extract for in vitro translation
Comparison of methods:
| Parameter | Recombinant Protein | mRNA Expression |
|---|---|---|
| Concentration control | High | Variable |
| Reproducibility | High | Depends on extract quality |
| Ease of use | Requires protein purification | Simpler for difficult-to-purify proteins |
| Suitability for complexes | Limited | Excellent for protein complexes |
| Time requirement | Immediate use | Requires translation time |
The choice between these methods depends on experimental requirements, protein properties, and whether protein complexes need to be reconstituted .
For optimal purification of His-tagged UPF0668 protein C10orf76 homolog:
Immobilized Metal Affinity Chromatography (IMAC):
Use Ni-NTA or Co2+-based resins for primary capture
Employ a gradient elution with increasing imidazole concentration (20-250 mM)
Monitor elution fractions via SDS-PAGE
Secondary Purification:
Apply size exclusion chromatography to remove aggregates and achieve >90% purity
Consider ion exchange chromatography if charged contaminants remain
Buffer Optimization:
The purified protein typically achieves >90% purity as determined by SDS-PAGE analysis and can be concentrated to the required levels for experimental applications .
To optimize expression of Recombinant Xenopus laevis UPF0668 protein C10orf76 homolog in E. coli:
Strain Selection:
BL21(DE3) derivatives are commonly used for their reduced protease activity
Rosetta or CodonPlus strains help overcome codon bias issues
Expression Conditions:
Induction at OD600 of 0.6-0.8 with 0.1-1.0 mM IPTG
Lower temperature expression (16-25°C) may improve solubility
Extended expression times (overnight) at lower temperatures
Media Optimization:
Rich media (LB, TB, 2YT) for higher yield
Auto-induction media for time-efficient expression
Consider supplementing with trace elements and additional glucose
Solubility Enhancement:
Co-expression with chaperones if solubility is an issue
Addition of solubility-enhancing fusion tags (in addition to His-tag)
Optimization of lysis conditions (detergents, salt concentration)
Monitoring expression levels at different timepoints via SDS-PAGE and ensuring proper sample preparation (sonication, French press) can significantly improve yield and quality of the recombinant protein.
When facing aggregation of Recombinant Xenopus laevis UPF0668 protein C10orf76 homolog:
Optimize Reconstitution Conditions:
Reduce protein concentration during initial reconstitution
Add reconstitution buffer slowly while gently rotating the vial
Avoid vigorous shaking or vortexing that can cause protein denaturation
Buffer Composition Adjustments:
Test different pH values (typically 7.0-8.0)
Include stabilizing agents like 1-5% glycerol or 0.1-0.5M NaCl
Consider low concentrations (1-5 mM) of reducing agents like DTT or β-mercaptoethanol
Temperature Management:
Perform reconstitution at 4°C rather than room temperature
Allow slow warming to experimental temperature
Filtration Techniques:
Use a 0.22 μm filter to remove larger aggregates
Consider centrifugation at 14,000g for 10 minutes to pellet insoluble material
If aggregation persists, dialyzing the protein against fresh buffer or performing size exclusion chromatography can help remove aggregated species before experimental use.
Researchers face several challenges when working with UPF0668 protein C10orf76 homolog in Xenopus egg extracts:
Extract Compatibility:
Depletion Efficiency:
Incomplete immunodepletion
Co-depletion of interacting partners
Solution: Multiple rounds of immunodepletion; careful validation of depletion specificity
Protein Activity Preservation:
Concentration Effects:
Extract Quality Variation:
Batch-to-batch variability of Xenopus egg extracts
Solution: Include appropriate controls; perform experiments with multiple extract preparations
Documenting these challenges and solutions in laboratory protocols can significantly improve experimental reproducibility.
To investigate structure-function relationships in UPF0668 protein C10orf76 homolog:
Domain Identification and Mutation Strategy:
Analyze the 689-amino acid sequence to identify conserved domains
Design point mutations or domain deletions based on sequence conservation
Focus on highly conserved residues or motifs across species
Recombinant Expression of Mutants:
Generate expression constructs with specific mutations
Express in E. coli using the same protocol as wild-type protein
Compare expression levels and solubility with wild-type
Functional Assay Design:
Structural Analysis:
Perform circular dichroism to assess secondary structure changes
Consider limited proteolysis to identify structural domains
When possible, obtain crystal structures of wild-type and mutant proteins
This approach can reveal critical residues for protein function and provide insights into the molecular mechanisms of this poorly characterized protein.
Several complementary techniques can identify interaction partners of UPF0668 protein C10orf76 homolog:
Immunoprecipitation from Xenopus Egg Extracts:
Use antibodies against the UPF0668 protein to pull down protein complexes
Analyze co-precipitating proteins via mass spectrometry
Validate interactions via reciprocal immunoprecipitation
Proximity-Dependent Labeling:
Express the protein fused to BioID or APEX2 in Xenopus systems
Allow biotin labeling of proximal proteins
Purify biotinylated proteins and identify by mass spectrometry
Yeast Two-Hybrid Screening:
Use the UPF0668 protein as bait against a Xenopus cDNA library
Screen for positive interactions under various stringency conditions
Validate using other methods in Xenopus systems
In Vitro Binding Assays:
Express and purify potential binding partners
Perform pull-down assays with recombinant His-tagged UPF0668 protein
Quantify binding affinities using techniques like surface plasmon resonance
Combining these approaches provides a comprehensive view of the protein's interaction network and potential functional roles in Xenopus laevis systems.